Artificial Pancreas Improves Glucose Control by 15%, Benefits Type 1 Diabetes Patients
January 30, 2013 5:55 PM
comment(s) - last by
Continual glucose monitor (left), pump worn on the belt that injects insulin under the patient’s skin (right), and a controller (a handheld smart phone)
(Source: Institut de recherches cliniques de Montreal)
Type 1 diabetics are expected to benefit from the new dual-hormone treatment
type 1 diabetic
is a full-time job, but a system that acts as an artificial pancreas could offer a bit of relief for those struggling to keep their glucose regulated.
An IRCM research team, led by Dr. Rémi Rabasa-Lhoret, have performed the first trial that compares an artifical pancreas system to a traditional diabetes treatment, and found that the artificial pancreas resulted in better glucose control.
The artificial pancreas is a dual-hormone system that
and glucagon automatically through the use of a continuous glucose monitor (CGM) and advanced algorithm.
The algorithm obtains data from the CGM, and it calculates the amount of insulin required. It will also calculate the required glucagon, if needed. Insulin lowers blood sugar while glucagon raises it, preventing the diabetic from experiencing hypoglycemia. Hypoglycemia is the result of blood sugar dropping too low, and can result in confusion and even loss of consciousness.
Once the insulin and glucagon is calculated, the CGM sends it to the wireless pump, and it automatically administers the proper dose of the hormones.
While pumps are available to diabetics today, the sensors must be checked frequently and the pump's dosage must be adjusted. This new system does everything without any interference from the person wearing it.
"Approximately two-thirds of patients don't achieve their target range with current treatments," said Dr. Rabasa-Lhoret. "The artificial pancreas could help them reach these targets and reduce the risk of hypoglycemia, which is feared by most patients and remains the most common adverse effect of insulin therapy. In fact, nocturnal hypoglycemia is the main barrier to reaching glycemic targets."
In the study, 15 type 1 diabetic adults that used insulin pumps for at least three months prior to the study were sent to IRCM's facility for two, 15-hour visits. During the visits, their glucose levels were monitored as they exercised on a stationary bike. They were also given an evening meal and a snack, and were sent to bed.
It turns out that the addition of glucagon and the algorithm for calculated release helped participants avoid hypoglycemia during the night. In fact, those with the dual-hormone treatment had 15 percent better glucose control than those with conventional pump treatment.
the artificial pancreas
had an 8-fold reduction in the risk of hypoglycemia, and a 20-fold reduction in the risk of hypoglycemia during the night.
This article is over a month old, voting and posting comments is disabled
Knew it was coming...
1/31/2013 7:07:21 AM
I've been a diabetic for about uggghh, 20 years. I've been on a wireless insulin pump (Insulet Corps Omnipod) system since 2006. It's been fantastic. I'm not super active, but I didn't want wires hanging out and possibly being grabbed by something if I'm working in a server cabinet or whatever.
A couple of years ago, the specialist recommended a continuous blood sugar monitor...I always thought it was just a matter of time before someone put both pump and continuous monitor together in a package.
The pump has made my life MUCH MUCH easier and while there are considerations to be mindful of when you're wearing them, they are a godsend for keeping numbers more in line with where they need to be. With diabetes causing many health issues in the longterm, having tighter control from the outset almost alleviates all of them. Kudos for the ongoing research for a system like this.
"We can't expect users to use common sense. That would eliminate the need for all sorts of legislation, committees, oversight and lawyers." -- Christopher Jennings
FDA Releases New Guidelines to Speed Up Artificial Pancreas Development
December 2, 2011, 1:32 PM
Researchers Use Stem Cells to Treat Diabetes in Mice
February 21, 2008, 1:05 PM
Crunch Time For Diabetes Research
June 29, 2007, 12:54 AM
Star Wars Spinoff Film "Rogue One", Theme Park Attractions Announced
August 17, 2015, 12:20 PM
SpaceX Falcon 9's Seventh Supply Mission to ISS Ends w/ Fiery Stage 1 Explosion
June 28, 2015, 1:10 PM
Cool Science Video: Glowing Millipede Prowls the Nevada Desert
May 18, 2015, 12:00 PM
Newly Discovered Costa Rican Glass Frog is Kermit's Doppelgänger
April 22, 2015, 11:26 AM
Researchers Hope to Find "Exotic" Lifeforms Inside Crater of Dinosaur Killing Meteor
April 14, 2015, 8:47 PM
Mathematician's Sociological Formulation May Explain the "Hipster Paradox"
April 14, 2015, 1:13 PM
Most Popular Articles
Why the U.S. Won't be Able to Ban Google's New Huawei Marshmallow Flagship Phone
October 3, 2015, 5:27 PM
Microsoft Band 2 Stays Focused on Fitness, Debuts Oct. 30, Priced at $249
October 6, 2015, 9:16 PM
Tag Heuer Admits Its $1,800 Smartwatch Was Inspired By Apple -- Price-Wise
September 30, 2015, 6:32 PM
Apple's First Fixes to iOS 9 Land w/ iOS 9.0.1 Release
September 23, 2015, 6:11 PM
Breaking Bad: How to Crash Google's Chrome Browser With Just 8 Characters
September 23, 2015, 11:08 AM
Latest Blog Posts
Sceptre Airs 27", 120 Hz. 1080p Monitor/HDTV w/ 5 ms Response Time for $220
Dec 3, 2014, 10:32 PM
Costco Gives Employees Thanksgiving Off; Wal-Mart Leads "Black Thursday" Charge
Oct 29, 2014, 9:57 PM
"Bear Selfies" Fad Could Turn Deadly, Warn Nevada Wildlife Officials
Oct 28, 2014, 12:00 PM
The Surface Mini That Was Never Released Gets "Hands On" Treatment
Sep 26, 2014, 8:22 AM
ISIS Imposes Ban on Teaching Evolution in Iraq
Sep 17, 2014, 5:22 PM
More Blog Posts
Copyright 2015 DailyTech LLC. -
Terms, Conditions & Privacy Information